Jiangsu Apon Medical Technology Co Ltd Class A - Asset Resilience Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has an Asset Resilience Ratio of 1.44% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Jiangsu Apon Medical Technology Co Ltd C strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2024)
This chart shows how Jiangsu Apon Medical Technology Co Ltd Class A's Asset Resilience Ratio has changed over time. See 300753 equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Jiangsu Apon Medical Technology Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangsu Apon Medical Technology Co Ltd C stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥12.00 Million | 1.44% |
| Total Liquid Assets | CN¥12.00 Million | 1.44% |
Asset Resilience Insights
- Limited Liquidity: Jiangsu Apon Medical Technology Co Ltd Class A maintains only 1.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiangsu Apon Medical Technology Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare Jiangsu Apon Medical Technology Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2023–2024)
The table below shows the annual Asset Resilience Ratio data for Jiangsu Apon Medical Technology Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.12% | CN¥1.00 Million ≈ $146.33K |
CN¥863.49 Million ≈ $126.36 Million |
0.00pp |
| 2023-12-31 | 0.12% | CN¥1.00 Million ≈ $146.33K |
CN¥859.57 Million ≈ $125.78 Million |
-- |
About Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more